Claire Woodward
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
18
Citations
1,333
Est. group size
—
Recurring co-author estimate
Active years
41
Publishing since 1985
Claire Woodward's work centers on the structure and dynamics of proteins, particularly those involved in the immune system, with applications toward designing immunotherapies. Recent projects span adaptive immune proteins (such as MHC-I antigen presentation), drug development like targeted protein degraders, and biophysical studies of molecular conformational changes.
Publication activity has been low but steady over the last decade, averaging about one paper per year with a modest cluster of output in 2023-2025.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- First-in-human study to assess the safety, pharmacokinetics, and pharmacodynamics of ARV-102, a PROTAC LRRK2 degrader, in healthy volunteers
Parkinsonism & Related Disorders · 2025
- CHARACTERIZING THE STRUCTURE AND DYNAMICS OF ADAPTIVE IMMUNE PROTEINS TO INFORM IMMUNOTHERAPY DESIGN
ScholarlyCommons (University of Pennsylvania) · 2025
- An age-old problem or an old-age problem? A UK survey of attitudes, historical use and recommendations by healthcare professionals to use healthcare apps
BMC Geriatrics · 2023
- Mechanistic aspects of tapasin-mediated antigen presentation revealed by structure of a tapasin/MHC-I complex
The Journal of Immunology · 2023
- Irreversibility of Conformational Changes and ZN2+Binding to DNA
Biophysical Journal · 2020
- BMC Geriatrics×1
- Parkinsonism & Related Disorders×1
- Discover Psychology×1
- PLoS ONE×1
- Biophysical Journal×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile